|Articles|December 1, 2017
- Pharmaceutical Executive-12-01-2017
- Volume 37
- Issue 12
Pharmaceutical Executive, December 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Global Health: Fighting the Good Fightabout 8 years ago
Global Health: Partnerships Hold the Keyabout 8 years ago
First Foray into Digital Adherenceabout 8 years ago
Global Health: Messages of Hopeabout 8 years ago
A Year of Transformation for Science & Medicineabout 8 years ago
Access and Reimbursement for Adoptive T-Cell Transfer Drugsabout 8 years ago
Will Europe Turn a Corner in Personalized Medicine?about 8 years ago
Fulfilling the Vision of Science: AstraZeneca's Ruud Dobberabout 8 years ago
Country Report: CanadaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
3
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5